0
0
Industry
Geography
Report Type
Themes
Price
Publication date
Published Date
  • Product Insights

    $100 | November 2023
    Product Insights

    Tel Yitzhak Reservoir Solar PV Park

    Tel Yitzhak Reservoir Solar PV Park is a solar PV project located in Center, Israel. The project is owned and developed by S~energy Renewable Energy Ltd. The project came online in 2022. Empower your strategies with our Tel Yitzhak Reservoir Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....

  • Macroeconomic Analysis

    $500 | January 2024
    Macroeconomic Analysis

    Israel PESTLE Insights – A Macroeconomic Outlook Report

    Transport, storage and communication activities contributed 15.6% to Israel’s gross value added (GVA) in 2022, followed by mining, manufacturing and utilities activities (13.8%), and wholesale, retail and hotels activities (10.8%). In nominal terms, the three sectors are forecast to grow by 7.0%, 7.2%, and 6.9%, respectively, in 2023. Tel Aviv and Jerusalem accounted for 58.8% of the country’s GDP and 59.4% of Israel’s population in 2022, according to GlobalData.

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Polycystic Ovarian Syndrome – Drugs In Development, 2023

    Global Markets Direct’s, ‘Polycystic Ovarian Syndrome - Drugs In Development, 2023’, provides an overview of the Polycystic Ovarian Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Polycystic Ovarian Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Encephalomyelitis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Encephalomyelitis - Drugs In Development, 2023’, provides an overview of the Encephalomyelitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Encephalomyelitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Arrhythmias – Drugs In Development, 2023

    Global Markets Direct’s, ‘Arrhythmias - Drugs In Development, 2023’, provides an overview of the Arrhythmias pipeline landscape. The report provides comprehensive information on the therapeutics under development for Arrhythmias, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Colitis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Colitis - Drugs In Development, 2023’, provides an overview of the Colitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Colitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Ovarian Disease – Drugs In Development, 2023

    Global Markets Direct’s, ‘Ovarian Disease - Drugs In Development, 2023’, provides an overview of the Ovarian Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ovarian Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Retinal Degeneration – Drugs In Development, 2023

    Global Markets Direct’s, ‘Retinal Degeneration - Drugs In Development, 2023’, provides an overview of the Retinal Degeneration pipeline landscape. The report provides comprehensive information on the therapeutics under development for Retinal Degeneration, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Endometriosis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Endometriosis - Drugs In Development, 2023’, provides an overview of the Endometriosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Endometriosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Atherosclerosis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Atherosclerosis - Drugs In Development, 2023’, provides an overview of the Atherosclerosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Atherosclerosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.